In contrast to the CON group, the PCOS group scored a statistically significant drop in the mean area percentage of Bcl2 positive immunoexpression and its cardiac levels, which were notably increased following adropin and/or Tirze-treated treatment (Figure 9F). Here, BCL2 is linked to polycystic ovary syndrome.